ATELLICA TM IM FIBROSIS HEPÁTICA (ELF) - COFEPRIS Registration 67R2019 SSA
Access comprehensive regulatory information for ATELLICA TM IM FIBROSIS HEPÁTICA (ELF) (ATELLICA TM IM FIBROSIS HEPÁTICA (ELF)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 67R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on January 25, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
LA PRUEBA ATELLICA ™ IM ENHANCED LIVER FIBROSIS (ELF) ES UN ENSAYO DE ÍNDICE MULTIVARIADO DE DIAGNÓSTICO IN VITRO DISEÑADO PARA PROPORCIONAR UNA PUNTUACIÓN ÚNICA DE ELF AL COMBINAR EN UN ALGORITMO LAS MEDICIONES CUANTITATIVAS DE ÁCIDO HIALURÓNICO (HA), PR
THE ATELLICA ™ IM ENHANCED LIVER FIBROSIS (ELF) TEST IS A MULTIVARIATE IN VITRO DIAGNOSTIC INDEX ASSAY DESIGNED TO PROVIDE A UNIQUE ELF SCORE BY COMBINING QUANTITATIVE MEASUREMENTS OF HYALURONIC ACID (HA), PR